🎙️ New podcast: Prof @adrianisaacs.bsky.social discusses frontotemporal dementia: from how fruit flies are helping, to the role of DNA repeat expansions in disease, and why lipids might protect the brain. On UCL's Brain Stories pod - listen here ⬇️

Dr Sevda Boyanova (UK DRI at UCL) explores two mutations associated with frontotemporal dementia and ALS in her latest study. She delves into her research on behavioural analysis of dementia mouse models in a Q&A with @dmmjournal.bsky.social 👉 buff.ly/nyTmFrS

❓ How can AI help us understand Alzheimer's risk? Discover how Prof Valentina Escott-Price's team are paving the way in using AI methods to predict Alzheimer's risk on a large scale.

Huge congrats to @mbourdenx.bsky.social, Dr Sophie Morse & Dr Wioleta Zelek who have today been awarded prestigious Future Leader Fellowships from @ukri.org! 🙌 🥳 Find out more about their projects 👉 buff.ly/VPFkvna

Congratulations to Dr Mootaz Salman, who has been awarded the Bayliss-Starling Prize Lecture 2025 by @physoc.bsky.social! 🎉 👏 The award highlights Dr Salman’s pioneering work at the interface of neuroscience, physiology, and bioengineering👉 buff.ly/vk0YZWe

At DMM, we #LovePostdocs and for #NPAW2025, we are highlighting remarkable postdocs from our 'First person' series. Sevda Boyanova, a postdoc in the Wiseman lab at UCL, UK, is investigating behavioural analysis of mouse models of aspects of dementia. doi.org/10.1242/dmm.... @ukdri.ac.uk

🧠 Delighted to launch a new postdoc fellowship programme with India's Centre for Brain Research 🙌 🇮🇳 🇬🇧 4-year fellowships in Bangalore developing scalable tools for dementia diagnosis harnessing India's diverse population cohorts Rolling deadline ⏰ Find out more 👉 www.ukdri.ac.uk/news-and-eve...

❓Where does Alzheimer’s begin? Find out how Dr Marc Busche’s team (UK DRI at UCL) have been using specialised techniques to examine cells deep in the brain, to unlock valuable information as to the earliest stages of Alzheimer’s disease.

Webinar: Could DNA repair hold the key to treating Huntingtons disease?🧬 Join UK DRI Group Leaders Profs Sarah Tabrizi & Gabriel Balmus as they dig into the latest discoveries and therapeutic breakthroughs from the field 🗓️ Mon 29 Sep 🕓 4-5pm (BST) Register free 👉 www.ukdri.ac.uk/events/rethi...

We’re excited to announce we’re joining forces with the Alzheimer’s Disease Data Initiative! The aim: To analyse nearly 10K blood & spinal fluid samples from various UK DRI studies & cohorts - creating one of the largest NULISA-specific resources in the field Find out more 👉 tinyurl.com/3t4nbsdc

Cardiff University research is exploring an antibody-based therapy for Alzheimer's, backed by us as part of our £30m commitment to @ukdri.ac.uk . Designed to enter the brain and block key drivers of inflammation, it could protect brain cells and help fill a major treatment gap.

🌟 New job opportunity 🌟 📍 Based within the UK DRI at UCL Seeking a motivated, experienced, and self-driven individual to work on a project that aims to look at context-dependent regulation of gene expression in cell systems. 🗓️ Apply by 14 September 2025 📌 Full details 👉 tinyurl.com/43vnxau4

🎧 @selinawray.bsky.social & @caswell.bsky.social are back with a new Brain Stories episode; this time with Prof @adrianisaacs.bsky.social from @ukdri.ac.uk. They dive into Frontotemporal Dementia & the surprising role fruit flies play in research. Listen: soundcloud.com/uclsound/bra... #UCLDementia

As part of our partnership with @ukdri.ac.uk, we're funding @edinburgh-uni.bsky.social research into combination therapies for MND. By repurposing well-tolerated drugs targeting key drivers of disease, the team aims to fast-track promising combinations into MND-SMART – the UK's largest MND trial

🚨New Symposium Alert!🚨 🧠White Matter in Focus: Exploring the Role of Myelin & Oligodendrocytes in Neurodegeneration 📅 Date: Wed, 22nd Oct 📍 Location: Gonville & Caius College, Cambridge, UK #Neurodegeneration #Myelin #Oligodendrocytes #Neuroscience @caiuscollege.bsky.social @ukdri.ac.uk

Could AI one day help us predict changes in the brain and ultimately prevent dementia? Dr Mathieu Bourdenx, UK DRI at @uclbrainscience.bsky.social, is using an ‘AI scientist’, which he hopes could transform how we make scientific discoveries. Find out more 👉 www.ucl.ac.uk/brain-scienc...

❓How can living human brain tissue give us a deeper understanding of Alzheimer’s? Find out how Dr @clairedurrant1.bsky.social team use live brain cells to uncover how a toxic protein damages cells in Alzheimer’s

Research led by @tspiresjones.bsky.social reveals cats with dementia share hallmarks of humans with Alzheimer's 🐈 The study, which examined the brains of 25 cats of different ages after they had passed away, offers a valuable model for studying the condition in humans👉 buff.ly/iZ7gRPV

🌟 Calling visionary researchers! 🌟 We’re recruiting four exceptional Group Leaders to join our new Parkinson’s Research Centre, launched in partnership with @parkinsons.org.uk Apply here by 22 September 👉 buff.ly/2aPdAu2

New research by Dr Sevda Boyanova (UK DRI at UCL) compares the effects of 2 mutations linked to frontotemporal dementia & ALS. She discusses the new paper & her wider work investigating behavioural analysis of dementia mouse models in @dmmjournal.bsky.social👉 buff.ly/nyTmFrS

Thank you, Dr. Karen Duff, for sharing such valuable insights into the complexities of tau and amyloid in Alzheimer’s research. This important discussion highlights the critical questions moving the field forward. #Alzheimersresearch #amyloid #tau @ukdri.ac.uk

Postdoctoral Research Fellow position at Surrey Sleep Research Centre, led by Prof Derk-Jan Dijk. Focus on digital health, sleep, and dementia in a @ukdri.ac.uk funded project. Closing date: 9th September www.dementiaresearcher.nihr.ac.uk/job/research...

Recently, we were delighted to welcome @frankmcnallymp.bsky.social to the UK DRI at Edinburgh. Researchers shared how innovative approaches - from stem cell research in the lab to clinical trial design - are transforming the future of MND. Read more here👉 buff.ly/KmLhwCD

Could a vaccine help prevent dementia? Data suggests the shingles vaccine is linked to a lower risk of developing dementia, adding to evidence that viral infections could influence brain health. 🎙️@tspiresjones.bsky.social breaks down the findings on BBC Radio 4's Inside Health ⬇️

🌟 Don't miss out on this opportunity for a position as Senior Clinical Study Manager in the UK DRI Core team in partnership with Health Data Research UK (HDR UK) 🌟 🗓️ Deadline: Monday 1 September Find out more & Apply 👉 lnkd.in/eD79PUrd

🧠 At the UK DRI, Dr Andrea Serio (@andreaserio.bsky.social) is engineering “minibrains” - lab-grown neural models that combine engineering, neuroscience & regenerative medicine. These models will help us better understand dementia and accelerate new treatments.

Senior Clinical Study Manager, London with @ukdri.ac.uk & HDR UK. Lead the Brain Health Community Assessment for Trials Service in the Dementia Trials Accelerator until March 2027. www.dementiaresearcher.nihr.ac.uk/job/senior-c...

Sequencing Manager / Administrator at UK DRI, University of Cambridge. Support research in neurodegeneration with Professor Mina Ryten. Centre admin, coordination, and delivery. Closing date: 31st August @ukdri.ac.uk www.dementiaresearcher.nihr.ac.uk/job/sequenci...

Rejection is part of research — but it doesn’t have to be the end of the road. 🎙️ This podcast is full of honest stories, resilience, and practical tips for turning setbacks into progress. Listen to @sj-marzi.bsky.social , Dayne Beccano and others share their experiences of rejection

The Dementia Trials Accelerator, led by the UK DRI & Health Data Research UK, is working to tackle a major challenge in dementia research: clinical trial recruitment - speeding up the path to new treatments. More via Citeline's Pink Sheet ⬇️

🌟 Don't miss out on this opportunity for a position as Science Portfolio Manager in the UK DRI Core team 🌟 🗓️ Deadline: Monday 1 September 📍Based at our office in London / Hybrid Find out more & Apply 👉 lnkd.in/epEaTr22

Fantastic to hear from Dr Nathasia Muwanigwa (UK DRI at UCL) in our latest blog post👏 Nathasia ran an engagement event alongside Dr Dayne Beccano-Kelly & Dr Moïse Roche, aiming to engage people aged 60+ from Black communities in a panel discussion about dementia👉 buff.ly/IgK1PYj

⭐ Are you a visionary researcher with an interest in Parkinson’s?⭐ We are recruiting for 4️⃣ outstanding Group Leaders to join our new Parkinson’s Research Centre in partnership with @parkinsons.org.uk 🙌 Apply here by 22 September👉 buff.ly/2aPdAu2

🎥 Blood Biomarkers: Testing for Alzheimer’s Disease 🎥 Discover the latest breakthroughs in blood-based biomarkers with Professor Jonathan Schott (UK DRI at UCL), explaining how blood tests are reshaping Alzheimer’s diagnosis. www.youtube.com/watch?v=3fLl...

Research by @tspiresjones.bsky.social & @clairedurrant1.bsky.social shows that tau spreads via synapses in PSP - a rare & devastating neurodegenerative disease with no effective treatments👉 buff.ly/xQ65CeM STV News reports ⬇️

🎙️ Podcast Episode: Between the Signals
What is motor neuron disease?🎙️ 🧠 What is motor neuron disease (MND)?
 🔍 How is it diagnosed?
 💡 What are the current treatment options? 🎙️ Listen now on all major podcast platforms or watch on YouTube 👉 lnkd.in/e6T9f4Xc

Exciting new opportunity for a position as a Research Technician in the The Bartels Lab at the UK DRI at UCL 🌟 🗓️ Deadline: Sunday 17 August Find out more & Apply 👉 www.ucl.ac.uk/work-at-ucl/...

Congratulations to Dr Deepak Khuperkar (UK DRI at King's) who has been awarded the prestigious King's Prize Fellowship and Professor Anthony Mellows medal. Read the full story 👉 www.kcl.ac.uk/news/dr-deep... @kingscollegelondon.bsky.social

Very excited that this is official now! Lots of setting up currently but will be recruiting soon!!

New opportunity for a Senior Clinical Study Manager in partnership with HDR UK, as part of the new Dementia Trials Accelerator 🌟 Read more 👉https://careers.ukdri.ac.uk/jobs/6078787-senior-clinical-study-manager-fixed-term-contract-until-end-march-2027?promotion=1578188-trackable-share-link-scsm-li

Could motor neuron disease (MND) be treated with a simple oral drug? 💊 With funding from us, @ukdri.ac.uk researchers at @ucl.ac.uk are testing 2 compounds that boost Stathmin-2. This protein is key to nerve cell health and could restore function in nerve cells affected by MND and FTD.

Last month, the UK DRI's Dr Nathasia Muwanigwa & Dr Dayne Beccano-Kelly, alongside Dr Moïse Roche (UCL), led a discussion on dementia with 60+ attendees from Black African & Caribbean communities. Nathasia reflects on the experience in this excellent blog post👉 buff.ly/PQ6KXUf

Delighted to welcome a new Group Leader to our flagship vascular dementia research centre with @thebhf.bsky.social 🎉👏 Prof Catherine Hall @cathnaledi.bsky.social and her team will examine how changes in blood flow & oxygen supply drive the onset of vascular dementia & Alzheimer’s👉 buff.ly/gyouoEV

Exciting new opportunity in the UK DRI Core team for a Science Portfolio Manager!🌟 Help support the Institute's mission to transform the lives of people living with or at risk of a neurodegenerative condition 🎯 🗓️ Deadline: 1 Sept Read more 👉 careers.ukdri.ac.uk/jobs/6168849...

It was a pleasure to host @marcaurelbusche.bsky.social for a special UK DRI webinar last week on how circuits fail in Alzheimer's disease, and hear about his lab's recent incredible findings 🧠 If you missed it, catch up here 👇 youtu.be/JzPFyO4ef-I?...

🤔 How do we help ensure breakthroughs in the lab make a difference for those living with a neurodegenerative condition? And could human data mining provide a solution? 🧠 Find out more in our latest feature 👉 www.ukdri.ac.uk/news-and-eve...

We're pleased to announce that the Dementia Trials Accelerator, spearheaded by the UK DRI & Health Data Research UK, is joining forces with @imperialcollegeldn.bsky.social's REACT programme & Inuvi to streamline dementia trial recruitment 🙌 Find out more 👉 buff.ly/Ip7QeLT

We hope everyone is enjoying #AAIC2025! 🥳 If you're at the conference, be sure to stop by and visit our partner the Centre for Brain Research, Indian Institute for Science, at booth 1638, to hear about their cutting-edge research into brain ageing 👏

Early results presented at #AAIC2025 indicate new drug trontinemab could clear amyloid faster than lecanemab or donanemab - with 9 in 10 people experiencing amyloid clearance within 28 weeks. UK DRI researchers respond to the news👉 buff.ly/u55W2D7

✍️ Lifestyle Interventions to Improve Cognition in Later Life - When is Enough Enough? New @jama.com Editorial from UK DRI Group Leader Prof @jmschott.bsky.social following the presentation of primary results of US POINTER 👉 jamanetwork.com/journals/jam...